comparison of oro-antral fistula closure techniques

Not Applicable

Recruiting

• Conditions: oro-antral fistula.; Unspecified lesions of oral mucosa; K13.70

• Registration Number: IRCT20200922048799N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

Patients with OAF over 18 years,
symptoms of maxillary sinusitis,
ASA 1 and 2,
OAF larger than 5 mm
OLD (one month to 6 months after fistula)

Exclusion Criteria

Patients under 18 years,
ASA above 2,
previous failed treatments,
history of microvascular and post-diabetes microvascular, metabolic bone disorders, history of renal failure, head and neck radiotherapy, patients under chemotherapy, pregnancy, drug or alcohol use,
poor oral hygiene, periodontal disease, a gingival bleeding index above 20%
maxillary fracture,
presence of fixation devices or foreign bodies in the sinus,
medication-related osteonecrosis of the jaw (MRONJ), or the presence of osteoradionecrosis.
patients who refuse to participate in follow-up sessions

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Wound dehiscence in clinical observation,. Timepoint: one-week, one-month, three-month, and six-month. Method of measurement: clinical observation.;Infection in clinical observation,. Timepoint: one-week, one-month, three-month, and six-month. Method of measurement: infection signs including edema, erythema, pus or hotness.;Swelling in clinical observation,. Timepoint: one-week, one-month, three-month, and six-month. Method of measurement: clinical evaluation.;Oro-antral fistula in clinical observation,. Timepoint: one-week, one-month, three-month, and six-month. Method of measurement: clinical evaluation.